Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.

Turner NA, Hamasaki T, Doernberg SB, Lodise TP, King HA, Ghazaryan V, Cosgrove SE, Jenkins TC, Liu C, Sharma S, Zaharoff S, Wahid L, Renard VJ, Cook P, Raad I, Hachem R, Chaftari AM, Sims M, DeMarco C, Miller LG, McCarthy MW, Morse CG, Lucasti C, Forrest GN, Cherabuddi K, Polk C, Fazili T, Rupp ME, Thompson GR 3rd, Kim K, Strnad L, Schnee AE, McKinnell JA, Ramesh M, Silveira FP, McCarty TP, Lee TC, McDonald EG, Paolino K, Wiegand K, Wall A, Riccobene T, Patel R, Rappo U, Evans S, Chambers HF, Fowler VG Jr, Holland TL, Antibacterial Resistance Leadership Group

Open source

DOI
10.1001/jama.2025.12543
Published
2025 Aug 13
Container
JAMA
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2025.12543,
  title = {Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.},
  author = {Turner NA and Hamasaki T and Doernberg SB and Lodise TP and King HA and Ghazaryan V and Cosgrove SE and Jenkins TC and Liu C and Sharma S and Zaharoff S and Wahid L and Renard VJ and Cook P and Raad I and Hachem R and Chaftari AM and Sims M and DeMarco C and Miller LG and McCarthy MW and Morse CG and Lucasti C and Forrest GN and Cherabuddi K and Polk C and Fazili T and Rupp ME and Thompson GR 3rd and Kim K and Strnad L and Schnee AE and McKinnell JA and Ramesh M and Silveira FP and McCarty TP and Lee TC and McDonald EG and Paolino K and Wiegand K and Wall A and Riccobene T and Patel R and Rappo U and Evans S and Chambers HF and Fowler VG Jr and Holland TL and Antibacterial Resistance Leadership Group},
  year = {2025},
  journal = {JAMA},
  doi = {10.1001/jama.2025.12543},
  url = {https://doi.org/10.1001/jama.2025.12543}
}

RIS

TY  - JOUR
TI  - Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.
AU  - Turner NA
AU  - Hamasaki T
AU  - Doernberg SB
AU  - Lodise TP
AU  - King HA
AU  - Ghazaryan V
AU  - Cosgrove SE
AU  - Jenkins TC
AU  - Liu C
AU  - Sharma S
AU  - Zaharoff S
AU  - Wahid L
AU  - Renard VJ
AU  - Cook P
AU  - Raad I
AU  - Hachem R
AU  - Chaftari AM
AU  - Sims M
AU  - DeMarco C
AU  - Miller LG
AU  - McCarthy MW
AU  - Morse CG
AU  - Lucasti C
AU  - Forrest GN
AU  - Cherabuddi K
AU  - Polk C
AU  - Fazili T
AU  - Rupp ME
AU  - Thompson GR 3rd
AU  - Kim K
AU  - Strnad L
AU  - Schnee AE
AU  - McKinnell JA
AU  - Ramesh M
AU  - Silveira FP
AU  - McCarty TP
AU  - Lee TC
AU  - McDonald EG
AU  - Paolino K
AU  - Wiegand K
AU  - Wall A
AU  - Riccobene T
AU  - Patel R
AU  - Rappo U
AU  - Evans S
AU  - Chambers HF
AU  - Fowler VG Jr
AU  - Holland TL
AU  - Antibacterial Resistance Leadership Group
PY  - 2025
JO  - JAMA
DO  - 10.1001/jama.2025.12543
UR  - https://doi.org/10.1001/jama.2025.12543
ER  -

APA

NA, T., T, H., SB, D., TP, L., HA, K., V, G., SE, C., TC, J., C, L., S, S., S, Z., L, W., VJ, R., P, C., I, R., R, H., AM, C., M, S., C, D., LG, M., MW, M., CG, M., C, L., GN, F., K, C., C, P., T, F., ME, R., 3rd, T. G., K, K., L, S., AE, S., JA, M., M, R., FP, S., TP, M., TC, L., EG, M., K, P., K, W., A, W., T, R., R, P., U, R., S, E., HF, C., Jr, F. V., TL, H., & Group, A. R. L. (2025). Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2025.12543

Source records